Literature DB >> 19026781

Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms.

Raphael Margueron1, Guohong Li, Kavitha Sarma, Alexandre Blais, Jiri Zavadil, Christopher L Woodcock, Brian D Dynlacht, Danny Reinberg.   

Abstract

Polycomb group proteins are critical to maintaining gene repression established during Drosophila development. Part of this group forms the PRC2 complex containing Ez that catalyzes di- and trimethylation of histone H3 lysine 27 (H3K37me2/3), marks repressive to transcription. We report that the mammalian homologs Ezh1 and Ezh2 form similar PRC2 complexes but exhibit contrasting repressive roles. While PRC2-Ezh2 catalyzes H3K27me2/3 and its knockdown affects global H3K27me2/3 levels, PRC2-Ezh1 performs this function weakly. In accordance, Ezh1 knockdown was ineffectual on global H3K27me2/3 levels. Instead, PRC2-Ezh1 directly and robustly represses transcription from chromatinized templates and compacts chromatin in the absence of the methyltransferase cofactor SAM, as evidenced by electron microscopy. Ezh1 targets a subset of Ezh2 genes, yet Ezh1 is more abundant in nonproliferative adult organs while Ezh2 expression is tightly associated with proliferation, as evidenced when analyzing aging mouse kidney. These results might reflect subfunctionalization of a PcG protein during evolution.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19026781      PMCID: PMC3641558          DOI: 10.1016/j.molcel.2008.11.004

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  69 in total

1.  Histone methyltransferase activity of a Drosophila Polycomb group repressor complex.

Authors:  Jürg Müller; Craig M Hart; Nicole J Francis; Marcus L Vargas; Aditya Sengupta; Brigitte Wild; Ellen L Miller; Michael B O'Connor; Robert E Kingston; Jeffrey A Simon
Journal:  Cell       Date:  2002-10-18       Impact factor: 41.582

2.  Reconstitution and transcriptional analysis of chromatin in vitro.

Authors:  Woojin An; Robert G Roeder
Journal:  Methods Enzymol       Date:  2004       Impact factor: 1.600

3.  Nucleosome arrays reveal the two-start organization of the chromatin fiber.

Authors:  Benedetta Dorigo; Thomas Schalch; Alexandra Kulangara; Sylwia Duda; Rasmus R Schroeder; Timothy J Richmond
Journal:  Science       Date:  2004-11-26       Impact factor: 47.728

4.  Recruitment of PRC1 function at the initiation of X inactivation independent of PRC2 and silencing.

Authors:  Stefan Schoeftner; Aditya K Sengupta; Stefan Kubicek; Karl Mechtler; Laura Spahn; Haruhiko Koseki; Thomas Jenuwein; Anton Wutz
Journal:  EMBO J       Date:  2006-06-08       Impact factor: 11.598

5.  Polycomb complexes repress developmental regulators in murine embryonic stem cells.

Authors:  Laurie A Boyer; Kathrin Plath; Julia Zeitlinger; Tobias Brambrink; Lea A Medeiros; Tong Ihn Lee; Stuart S Levine; Marius Wernig; Adriana Tajonar; Mridula K Ray; George W Bell; Arie P Otte; Miguel Vidal; David K Gifford; Richard A Young; Rudolf Jaenisch
Journal:  Nature       Date:  2006-04-19       Impact factor: 49.962

6.  Control of developmental regulators by Polycomb in human embryonic stem cells.

Authors:  Tong Ihn Lee; Richard G Jenner; Laurie A Boyer; Matthew G Guenther; Stuart S Levine; Roshan M Kumar; Brett Chevalier; Sarah E Johnstone; Megan F Cole; Kyo-ichi Isono; Haruhiko Koseki; Takuya Fuchikami; Kuniya Abe; Heather L Murray; Jacob P Zucker; Bingbing Yuan; George W Bell; Elizabeth Herbolsheimer; Nancy M Hannett; Kaiming Sun; Duncan T Odom; Arie P Otte; Thomas L Volkert; David P Bartel; Douglas A Melton; David K Gifford; Rudolf Jaenisch; Richard A Young
Journal:  Cell       Date:  2006-04-21       Impact factor: 41.582

7.  Structural basis of EZH2 recognition by EED.

Authors:  Zhifu Han; Xinmiao Xing; Min Hu; Yin Zhang; Peiyuan Liu; Jijie Chai
Journal:  Structure       Date:  2007-10       Impact factor: 5.006

8.  The Drosophila esc and E(z) proteins are direct partners in polycomb group-mediated repression.

Authors:  C A Jones; J Ng; A J Peterson; K Morgan; J Simon; R S Jones
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

9.  Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein.

Authors:  Andrei Kuzmichev; Kenichi Nishioka; Hediye Erdjument-Bromage; Paul Tempst; Danny Reinberg
Journal:  Genes Dev       Date:  2002-11-15       Impact factor: 11.361

10.  PR-Set7 is a nucleosome-specific methyltransferase that modifies lysine 20 of histone H4 and is associated with silent chromatin.

Authors:  Kenichi Nishioka; Judd C Rice; Kavitha Sarma; Hediye Erdjument-Bromage; Janis Werner; Yanming Wang; Sergei Chuikov; Pablo Valenzuela; Paul Tempst; Ruth Steward; John T Lis; C David Allis; Danny Reinberg
Journal:  Mol Cell       Date:  2002-06       Impact factor: 17.970

View more
  364 in total

Review 1.  The roles and regulation of Polycomb complexes in neural development.

Authors:  Matthew Corley; Kristen L Kroll
Journal:  Cell Tissue Res       Date:  2014-11-01       Impact factor: 5.249

Review 2.  Functional Crosstalk Between Lysine Methyltransferases on Histone Substrates: The Case of G9A/GLP and Polycomb Repressive Complex 2.

Authors:  Chiara Mozzetta; Julien Pontis; Slimane Ait-Si-Ali
Journal:  Antioxid Redox Signal       Date:  2014-12-19       Impact factor: 8.401

3.  ALDH1A1 is a novel EZH2 target gene in epithelial ovarian cancer identified by genome-wide approaches.

Authors:  Hua Li; Benjamin G Bitler; Vinod Vathipadiekal; Marie E Maradeo; Michael Slifker; Caretha L Creasy; Peter J Tummino; Paul Cairns; Michael J Birrer; Rugang Zhang
Journal:  Cancer Prev Res (Phila)       Date:  2011-12-05

4.  Dynamic patterns of histone lysine methylation in the developing retina.

Authors:  Rajesh C Rao; Kissaou T Tchedre; Muhammad Taimur A Malik; Natasha Coleman; Yuan Fang; Victor E Marquez; Dong Feng Chen
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-07-29       Impact factor: 4.799

5.  Derepression of Polycomb targets during pancreatic organogenesis allows insulin-producing beta-cells to adopt a neural gene activity program.

Authors:  Joris van Arensbergen; Javier García-Hurtado; Ignasi Moran; Miguel Angel Maestro; Xiaobo Xu; Mark Van de Casteele; Anouchka L Skoudy; Matteo Palassini; Harry Heimberg; Jorge Ferrer
Journal:  Genome Res       Date:  2010-04-15       Impact factor: 9.043

Review 6.  EZH2: not EZHY (easy) to deal.

Authors:  Gauri Deb; Anup Kumar Singh; Sanjay Gupta
Journal:  Mol Cancer Res       Date:  2014-02-13       Impact factor: 5.852

7.  Geriatric muscle stem cells switch reversible quiescence into senescence.

Authors:  Pedro Sousa-Victor; Susana Gutarra; Laura García-Prat; Javier Rodriguez-Ubreva; Laura Ortet; Vanessa Ruiz-Bonilla; Mercè Jardí; Esteban Ballestar; Susana González; Antonio L Serrano; Eusebio Perdiguero; Pura Muñoz-Cánoves
Journal:  Nature       Date:  2014-02-12       Impact factor: 49.962

8.  Epithelial EZH2 serves as an epigenetic determinant in experimental colitis by inhibiting TNFα-mediated inflammation and apoptosis.

Authors:  Yongfeng Liu; Junjie Peng; Tongyu Sun; Ni Li; Le Zhang; Jiale Ren; Huairui Yuan; Shan Kan; Qiang Pan; Xiang Li; Yufeng Ding; Min Jiang; Xiaoji Cong; Minjia Tan; Yushui Ma; Da Fu; Sanjun Cai; Yichuan Xiao; Xiaoming Wang; Jun Qin
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-24       Impact factor: 11.205

9.  Geroconversion of aged muscle stem cells under regenerative pressure.

Authors:  Pedro Sousa-Victor; Eusebio Perdiguero; Pura Muñoz-Cánoves
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

10.  Enhancer of Zeste Homolog 2 Inhibition Stimulates Bone Formation and Mitigates Bone Loss Caused by Ovariectomy in Skeletally Mature Mice.

Authors:  Amel Dudakovic; Emily T Camilleri; Scott M Riester; Christopher R Paradise; Martina Gluscevic; Thomas M O'Toole; Roman Thaler; Jared M Evans; Huihuang Yan; Malayannan Subramaniam; John R Hawse; Gary S Stein; Martin A Montecino; Meghan E McGee-Lawrence; Jennifer J Westendorf; Andre J van Wijnen
Journal:  J Biol Chem       Date:  2016-10-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.